Overview

Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain

Status:
Not yet recruiting

Trial end date:
2026-05-21

Target enrollment:

Participant gender:

Summary

The brief purpose of this research study is to learn about the safety, tolerability, and efficacy of paraspinal intramuscular injection of CELZ-201-DDT in patients with chronic lower back pain.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Creative Medical Technology Holdings Inc